 | • レポートコード：MRC2-11QY11381 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はCISインスリンのグローバル市場について調査・分析したレポートです。種類別（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン）市場規模、用途別（I型・その他糖尿病、II型糖尿病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別CISインスリンの競争状況、市場シェア ・世界のCISインスリン市場：種類別市場規模 2015年-2020年（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン） ・世界のCISインスリン市場：種類別市場規模予測 2021年-2026年（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン） ・世界のCISインスリン市場：用途別市場規模 2015年-2020年（I型・その他糖尿病、II型糖尿病） ・世界のCISインスリン市場：用途別市場規模予測 2021年-2026年（I型・その他糖尿病、II型糖尿病） ・北米のCISインスリン市場分析：米国、カナダ ・ヨーロッパのCISインスリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのCISインスリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のCISインスリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのCISインスリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Novo Nordisk、Takeda Pharmaceuticals、Sanofi Aventis、Nanjing Xinbai Pharmaceutical、Oramed Pharmaceuticals、Merck、Boehringer Ingelheim、Biocon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body.
Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government.
Market Analysis and Insights: Global CIS Insulin Market
The global CIS Insulin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global CIS Insulin Scope and Market Size
CIS Insulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CIS Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eli Lilly
Novo Nordisk
Takeda Pharmaceuticals
Sanofi Aventis
Nanjing Xinbai Pharmaceutical
Oramed Pharmaceuticals
Merck
Boehringer Ingelheim
Biocon
Market segment by Type, the product can be split into
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin
Market segment by Application, split into
Type I and Other Diabetes
Type II Diabetes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CIS Insulin Revenue
1.4 Market by Type
1.4.1 Global CIS Insulin Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Long-Acting Analog
1.4.3 Rapid Acting Analog
1.4.4 Premixed Analog
1.4.5 Intermediate Insulin
1.4.6 Short Acting Insulin
1.4.7 Premixed Insulin
1.5 Market by Application
1.5.1 Global CIS Insulin Market Share by Application: 2020 VS 2026
1.5.2 Type I and Other Diabetes
1.5.3 Type II Diabetes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global CIS Insulin Market Perspective (2015-2026)
2.2 Global CIS Insulin Growth Trends by Regions
2.2.1 CIS Insulin Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CIS Insulin Historic Market Share by Regions (2015-2020)
2.2.3 CIS Insulin Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 CIS Insulin Market Growth Strategy
2.3.6 Primary Interviews with Key CIS Insulin Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top CIS Insulin Players by Market Size
3.1.1 Global Top CIS Insulin Players by Revenue (2015-2020)
3.1.2 Global CIS Insulin Revenue Market Share by Players (2015-2020)
3.1.3 Global CIS Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CIS Insulin Market Concentration Ratio
3.2.1 Global CIS Insulin Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CIS Insulin Revenue in 2019
3.3 CIS Insulin Key Players Head office and Area Served
3.4 Key Players CIS Insulin Product Solution and Service
3.5 Date of Enter into CIS Insulin Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global CIS Insulin Historic Market Size by Type (2015-2020)
4.2 Global CIS Insulin Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global CIS Insulin Market Size by Application (2015-2020)
5.2 Global CIS Insulin Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CIS Insulin Market Size (2015-2020)
6.2 CIS Insulin Key Players in North America (2019-2020)
6.3 North America CIS Insulin Market Size by Type (2015-2020)
6.4 North America CIS Insulin Market Size by Application (2015-2020)
7 Europe
7.1 Europe CIS Insulin Market Size (2015-2020)
7.2 CIS Insulin Key Players in Europe (2019-2020)
7.3 Europe CIS Insulin Market Size by Type (2015-2020)
7.4 Europe CIS Insulin Market Size by Application (2015-2020)
8 China
8.1 China CIS Insulin Market Size (2015-2020)
8.2 CIS Insulin Key Players in China (2019-2020)
8.3 China CIS Insulin Market Size by Type (2015-2020)
8.4 China CIS Insulin Market Size by Application (2015-2020)
9 Japan
9.1 Japan CIS Insulin Market Size (2015-2020)
9.2 CIS Insulin Key Players in Japan (2019-2020)
9.3 Japan CIS Insulin Market Size by Type (2015-2020)
9.4 Japan CIS Insulin Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia CIS Insulin Market Size (2015-2020)
10.2 CIS Insulin Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CIS Insulin Market Size by Type (2015-2020)
10.4 Southeast Asia CIS Insulin Market Size by Application (2015-2020)
11 India
11.1 India CIS Insulin Market Size (2015-2020)
11.2 CIS Insulin Key Players in India (2019-2020)
11.3 India CIS Insulin Market Size by Type (2015-2020)
11.4 India CIS Insulin Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America CIS Insulin Market Size (2015-2020)
12.2 CIS Insulin Key Players in Central & South America (2019-2020)
12.3 Central & South America CIS Insulin Market Size by Type (2015-2020)
12.4 Central & South America CIS Insulin Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly CIS Insulin Introduction
13.1.4 Eli Lilly Revenue in CIS Insulin Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Details
13.2.2 Novo Nordisk Business Overview
13.2.3 Novo Nordisk CIS Insulin Introduction
13.2.4 Novo Nordisk Revenue in CIS Insulin Business (2015-2020)
13.2.5 Novo Nordisk Recent Development
13.3 Takeda Pharmaceuticals
13.3.1 Takeda Pharmaceuticals Company Details
13.3.2 Takeda Pharmaceuticals Business Overview
13.3.3 Takeda Pharmaceuticals CIS Insulin Introduction
13.3.4 Takeda Pharmaceuticals Revenue in CIS Insulin Business (2015-2020)
13.3.5 Takeda Pharmaceuticals Recent Development
13.4 Sanofi Aventis
13.4.1 Sanofi Aventis Company Details
13.4.2 Sanofi Aventis Business Overview
13.4.3 Sanofi Aventis CIS Insulin Introduction
13.4.4 Sanofi Aventis Revenue in CIS Insulin Business (2015-2020)
13.4.5 Sanofi Aventis Recent Development
13.5 Nanjing Xinbai Pharmaceutical
13.5.1 Nanjing Xinbai Pharmaceutical Company Details
13.5.2 Nanjing Xinbai Pharmaceutical Business Overview
13.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Introduction
13.5.4 Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2015-2020)
13.5.5 Nanjing Xinbai Pharmaceutical Recent Development
13.6 Oramed Pharmaceuticals
13.6.1 Oramed Pharmaceuticals Company Details
13.6.2 Oramed Pharmaceuticals Business Overview
13.6.3 Oramed Pharmaceuticals CIS Insulin Introduction
13.6.4 Oramed Pharmaceuticals Revenue in CIS Insulin Business (2015-2020)
13.6.5 Oramed Pharmaceuticals Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck CIS Insulin Introduction
13.7.4 Merck Revenue in CIS Insulin Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Details
13.8.2 Boehringer Ingelheim Business Overview
13.8.3 Boehringer Ingelheim CIS Insulin Introduction
13.8.4 Boehringer Ingelheim Revenue in CIS Insulin Business (2015-2020)
13.8.5 Boehringer Ingelheim Recent Development
13.9 Biocon
13.9.1 Biocon Company Details
13.9.2 Biocon Business Overview
13.9.3 Biocon CIS Insulin Introduction
13.9.4 Biocon Revenue in CIS Insulin Business (2015-2020)
13.9.5 Biocon Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. CIS Insulin Key Market Segments
Table 2. Key Players Covered: Ranking by CIS Insulin Revenue
Table 3. Ranking of Global Top CIS Insulin Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CIS Insulin Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Long-Acting Analog
Table 6. Key Players of Rapid Acting Analog
Table 7. Key Players of Premixed Analog
Table 8. Key Players of Intermediate Insulin
Table 9. Key Players of Short Acting Insulin
Table 10. Key Players of Premixed Insulin
Table 11. Global CIS Insulin Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global CIS Insulin Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global CIS Insulin Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global CIS Insulin Market Share by Regions (2015-2020)
Table 15. Global CIS Insulin Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global CIS Insulin Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. CIS Insulin Market Growth Strategy
Table 21. Main Points Interviewed from Key CIS Insulin Players
Table 22. Global CIS Insulin Revenue by Players (2015-2020) (Million US$)
Table 23. Global CIS Insulin Market Share by Players (2015-2020)
Table 24. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CIS Insulin as of 2019)
Table 25. Global CIS Insulin by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players CIS Insulin Product Solution and Service
Table 28. Date of Enter into CIS Insulin Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 31. Global CIS Insulin Market Size Share by Type (2015-2020)
Table 32. Global CIS Insulin Revenue Market Share by Type (2021-2026)
Table 33. Global CIS Insulin Market Size Share by Application (2015-2020)
Table 34. Global CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 35. Global CIS Insulin Market Size Share by Application (2021-2026)
Table 36. North America Key Players CIS Insulin Revenue (2019-2020) (Million US$)
Table 37. North America Key Players CIS Insulin Market Share (2019-2020)
Table 38. North America CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 39. North America CIS Insulin Market Share by Type (2015-2020)
Table 40. North America CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 41. North America CIS Insulin Market Share by Application (2015-2020)
Table 42. Europe Key Players CIS Insulin Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players CIS Insulin Market Share (2019-2020)
Table 44. Europe CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 45. Europe CIS Insulin Market Share by Type (2015-2020)
Table 46. Europe CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 47. Europe CIS Insulin Market Share by Application (2015-2020)
Table 48. China Key Players CIS Insulin Revenue (2019-2020) (Million US$)
Table 49. China Key Players CIS Insulin Market Share (2019-2020)
Table 50. China CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 51. China CIS Insulin Market Share by Type (2015-2020)
Table 52. China CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 53. China CIS Insulin Market Share by Application (2015-2020)
Table 54. Japan Key Players CIS Insulin Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players CIS Insulin Market Share (2019-2020)
Table 56. Japan CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 57. Japan CIS Insulin Market Share by Type (2015-2020)
Table 58. Japan CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 59. Japan CIS Insulin Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players CIS Insulin Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players CIS Insulin Market Share (2019-2020)
Table 62. Southeast Asia CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia CIS Insulin Market Share by Type (2015-2020)
Table 64. Southeast Asia CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia CIS Insulin Market Share by Application (2015-2020)
Table 66. India Key Players CIS Insulin Revenue (2019-2020) (Million US$)
Table 67. India Key Players CIS Insulin Market Share (2019-2020)
Table 68. India CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 69. India CIS Insulin Market Share by Type (2015-2020)
Table 70. India CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 71. India CIS Insulin Market Share by Application (2015-2020)
Table 72. Central & South America Key Players CIS Insulin Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players CIS Insulin Market Share (2019-2020)
Table 74. Central & South America CIS Insulin Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America CIS Insulin Market Share by Type (2015-2020)
Table 76. Central & South America CIS Insulin Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America CIS Insulin Market Share by Application (2015-2020)
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Product
Table 81. Eli Lilly Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 82. Eli Lilly Recent Development
Table 83. Novo Nordisk Company Details
Table 84. Novo Nordisk Business Overview
Table 85. Novo Nordisk Product
Table 86. Novo Nordisk Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 87. Novo Nordisk Recent Development
Table 88. Takeda Pharmaceuticals Company Details
Table 89. Takeda Pharmaceuticals Business Overview
Table 90. Takeda Pharmaceuticals Product
Table 91. Takeda Pharmaceuticals Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 92. Takeda Pharmaceuticals Recent Development
Table 93. Sanofi Aventis Company Details
Table 94. Sanofi Aventis Business Overview
Table 95. Sanofi Aventis Product
Table 96. Sanofi Aventis Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 97. Sanofi Aventis Recent Development
Table 98. Nanjing Xinbai Pharmaceutical Company Details
Table 99. Nanjing Xinbai Pharmaceutical Business Overview
Table 100. Nanjing Xinbai Pharmaceutical Product
Table 101. Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 102. Nanjing Xinbai Pharmaceutical Recent Development
Table 103. Oramed Pharmaceuticals Company Details
Table 104. Oramed Pharmaceuticals Business Overview
Table 105. Oramed Pharmaceuticals Product
Table 106. Oramed Pharmaceuticals Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 107. Oramed Pharmaceuticals Recent Development
Table 108. Merck Company Details
Table 109. Merck Business Overview
Table 110. Merck Product
Table 111. Merck Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 112. Merck Recent Development
Table 113. Boehringer Ingelheim Business Overview
Table 114. Boehringer Ingelheim Product
Table 115. Boehringer Ingelheim Company Details
Table 116. Boehringer Ingelheim Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 117. Boehringer Ingelheim Recent Development
Table 118. Biocon Company Details
Table 119. Biocon Business Overview
Table 120. Biocon Product
Table 121. Biocon Revenue in CIS Insulin Business (2015-2020) (Million US$)
Table 122. Biocon Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CIS Insulin Market Share by Type: 2020 VS 2026
Figure 2. Long-Acting Analog Features
Figure 3. Rapid Acting Analog Features
Figure 4. Premixed Analog Features
Figure 5. Intermediate Insulin Features
Figure 6. Short Acting Insulin Features
Figure 7. Premixed Insulin Features
Figure 8. Global CIS Insulin Market Share by Application: 2020 VS 2026
Figure 9. Type I and Other Diabetes Case Studies
Figure 10. Type II Diabetes Case Studies
Figure 11. CIS Insulin Report Years Considered
Figure 12. Global CIS Insulin Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global CIS Insulin Market Share by Regions: 2020 VS 2026
Figure 14. Global CIS Insulin Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global CIS Insulin Market Share by Players in 2019
Figure 17. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CIS Insulin as of 2019
Figure 18. The Top 10 and 5 Players Market Share by CIS Insulin Revenue in 2019
Figure 19. North America CIS Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe CIS Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China CIS Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan CIS Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia CIS Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India CIS Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America CIS Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- インスリン薬・デリバリー技術の世界市場（～2026年） Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along w…
- インスリンデテミルの世界市場（～2026年） Market Analysis and Insights: Global Insulin Detemir Market The global Insulin Detemir market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Detemir Scope and Market Size Insulin Detemir market is segmented by Type, …
- インシュリン様成長因子Iの世界市場（～2026年） Market Analysis and Insights: Global Insulin Like Growth Factor I Market The global Insulin Like Growth Factor I market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Like Growth Factor I Scope and Market Size Insuli…